Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 5—May 2024
Research

Economic Burden of Acute Gastroenteritis among Members of Integrated Healthcare Delivery System, United States, 2014–2016

John F. Dickerson, Suzanne B. Salas, Judy Donald, Holly C. GroomComments to Author , Mi H. Lee, Claire P. Mattison, Aron J. Hall, and Mark A. Schmidt
Author affiliations: Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA (J.F. Dickerson, S.B. Salas, J. Donald, H.C. Groom, M.H. Lee, M.A. Schmidt); Cherokee Nation Assurance, Arlington, Virginia, USA (C.P. Mattison); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.P. Mattison, A.J. Hall)

Main Article

Table 2

Demographic characteristics and underlying conditions among pediatric medically attended acute gastroenteritis case-patients and age- and gender-matched comparators in an integrated health system in the Pacific Northwest of the United States, April 1, 2014–September 30, 2016*

EHR-derived measures MAAGE cases, n = 8,558† Comparators, N = 8,580 p value‡
Mean age, y (+SD)
6.0 (5.2)
6.3 (5.3)
<0.001
Sex, %
F 47.0 47.1 NA
M
53.0
52.9
NA
Race/ethnicity, %
Hispanic 18.0 11.7 <0.001
Non-Hispanic White 63.5 70.2 <0.001
Non-Hispanic other race 15.0 14.3 <0.001
Unknown
3.5
3.8
<0.001
Comorbidity, %§
Blood disease 0.7 0.6 0.384
Cancer 0.2 0.3 0.547
Diabetes 0.4 0.5 0.651
Heart disease 1.4 1.5 0.524
Immune disease 0.4 0.3 0.047
Kidney disease 0.4 0.4 0.800
Liver disease 0.02 0.03 0.655
Lung disease 8.1 6.6 <0.001
Metabolic disease 0.7 0.8 0.528
Neurologic disease 1.8 2.0 0.317

*All participants were Kaiser Permanente Northwest medical members, <18 y of age, with ≥1 encounter at the time of the study. EHR, electronic health records; NA, not applicable †Corresponds to 9,203 episodes; 834 MAAGE cases were comparators at some time in the study ‡Paired t-test or χ2 test. §Percentage with diagnosis codes from the International Classification of Diseases, 9th Revision or 10th Revision, in the 12 mo before index encounter date.

Main Article

Page created: April 10, 2024
Page updated: April 23, 2024
Page reviewed: April 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external